Anti-IL-6R tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-TNF therapy. A multicenter study of 25 patients - Calvo-Rio, V; Santos-Gomez, M; Calvo, I (Arthritis Rheumatol, 2016)